Suzhou Zelgen Biopharmaceuticals Co., Ltd. (688266.SS)
CNY 62.27
(-1.16%)
CNY 62.27
(-1.16%)
| Year | Eps | Eps Growth |
|---|---|---|
| 2023 | -1.09 CNY | 46.04% |
| 2022 | -2.02 CNY | -5.21% |
| 2021 | -1.92 CNY | -48.84% |
| 2020 | -1.29 CNY | 31.02% |
| 2019 | -1.87 CNY | 23.67% |
| 2018 | -2.45 CNY | -202.47% |
| 2017 | -0.81 CNY | -14.08% |
| 2016 | -0.71 CNY | 0.0% |
| Year | Eps | Eps Growth |
|---|---|---|
| 2024 Q1 | -0.15 CNY | 48.28% |
| 2024 Q2 | -0.10 CNY | 33.33% |
| 2024 Q3 | -0.12 CNY | -20.0% |
| 2023 Q4 | -0.29 CNY | 14.71% |
| 2023 FY | - CNY | 46.04% |
| 2023 Q3 | -0.34 CNY | -54.55% |
| 2023 Q2 | -0.22 CNY | 12.0% |
| 2023 Q1 | -0.25 CNY | 39.02% |
| 2022 FY | - CNY | -5.21% |
| 2022 Q3 | -0.52 CNY | 8.77% |
| 2022 Q2 | -0.57 CNY | -7.55% |
| 2022 Q1 | -0.53 CNY | 19.7% |
| 2022 Q4 | -0.41 CNY | 21.15% |
| 2021 Q2 | -0.41 CNY | -24.24% |
| 2021 Q1 | -0.33 CNY | 15.38% |
| 2021 FY | - CNY | -48.84% |
| 2021 Q4 | -0.66 CNY | -37.5% |
| 2021 Q3 | -0.48 CNY | -17.07% |
| 2020 Q4 | -0.39 CNY | -69.57% |
| 2020 Q3 | -0.23 CNY | 23.33% |
| 2020 Q1 | -0.28 CNY | 22.22% |
| 2020 FY | - CNY | 31.02% |
| 2020 Q2 | -0.30 CNY | -7.14% |
| 2019 FY | - CNY | 23.67% |
| 2019 Q4 | -0.36 CNY | -12.5% |
| 2019 Q3 | -0.32 CNY | 66.32% |
| 2019 Q2 | -0.95 CNY | 0.0% |
| 2019 Q1 | -0.95 CNY | 51.28% |
| 2018 Q4 | -1.95 CNY | 0.0% |
| 2018 FY | - CNY | -202.47% |
| 2017 FY | - CNY | -14.08% |
| 2016 FY | - CNY | 0.0% |